| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 阿江榄仁素; Arjungenin | CFN95039 | 58880-25-4 | C30H48O6 = 504.7 | 20mg | QQ客服：2056216494 |
| 二氢山芹醇 β-D-葡萄糖苷; Columbianetin beta-D-glucopyranoside | CFN95038 | 55836-35-6 | C20H24O9 = 408.4 | 5mg | QQ客服：2056216494 |
| 鸢尾甲苷A; Iristectorin A | CFN95037 | 37744-61-9 | C23H24O12 = 492.4 | 20mg | QQ客服：3257982914 |
| 20-葡萄糖人参皂苷R; 20-O-Glucoginsenoside Rf | CFN95036 | 68406-27-9 | C48H82O19 = 963.2 | 5mg | QQ客服：2159513211 |
| 2'-鼠李糖松果菊苷; 2'-Rhamnoechinacoside | CFN95035 | 1422390-59-7 | C41H56O24 = 932.9 | 10mg | QQ客服：2159513211 |
| 人参皂苷F5; Ginsenoside F5 | CFN95034 | 189513-26-6 | C41H70O13 = 771.0 | 20mg | QQ客服：3257982914 |
| Gymnoside III; Gymnoside III | CFN95033 | 899430-03-6 | C42H58O23 = 930.9 | 10mg | QQ客服：2056216494 |
| Dactylorhin A; Dactylorhin A | CFN95032 | 256459-34-4 | C40H56O22 = 888.9 | 20mg | QQ客服：3257982914 |
| 9-O-Acetyl-fargesol; 9-O-Acetyl-fargesol | CFN95031 | 449172-61-6 | C24H30O8 = 446.5 | 5mg | QQ客服：215959384 |
| 垫状卷柏三酚; Selaginellin | CFN95030 | 941269-84-7 | C34H24O5 = 512.6 | 5mg | QQ客服：3257982914 |
| 垫状卷柏三酚 F; Selaginellin F | CFN95029 | 1340493-24-4 | C34H24O6 = 528.6 | 5mg | QQ客服：2056216494 |
| 断马钱子酸; Secologanic acid | CFN95028 | 60077-46-5 | C16H22O10 = 374.3 | 20mg | QQ客服：2159513211 |
| Fargesol; Fargesol | CFN95027 | 128855-64-1 | C22H28O7 = 404.5 | 20mg | QQ客服：2159513211 |
| 3,4-O-dimethylcedrusin; 3,4-O-dimethylcedrusin | CFN95026 | 166021-14-3 | C21H26O6 = 374.4 | 10mg | QQ客服：3257982914 |
| 望春花黄酮醇苷I; Buddlenoid A | CFN95025 | 142750-32-1 | C30H26O13 = 594.5 | 5mg | QQ客服：215959384 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)